Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced today that its investigational drug TEV-53408 has received Fast ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibodyDesignation underscores the potential of ...

A celiac disease diagnosis can be overwhelming and life-altering. Dietitians share practical tips for managing this condition ...

I would have told you this wasn’t possible, absolutely not,” an immunologist said. “Today, I can say that it will happen. No ...

Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease.

Celiac disease is an immune system problem ... Things like over-the-counter and prescription medications, and vitamins and supplements might contain gluten. Wheat starch is commonly used as ...

New study demonstrates the efficacy of a promising celiac disease drug at the molecular level. ScienceDaily . Retrieved May 24, 2025 from www.sciencedaily.com / releases / 2024 / 06 / 240624125521.htm ...

A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ...